Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schnorr

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Experimental and Clinical Endocrinology|July 1, 1983
Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasiaF Stahl, D Schnorr, W Rohde, et al.
Dermatologische Monatschrift|August 1, 1978
[Influence of oral effective antiandrogens on fertility and sexuality in man and rat (author's transl)]S Engel, F Götz, F Stahl, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 18, 2003
[MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging]D Beyersdorff, U Darsow, C Stephan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1996
Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasiaK Jung, M Lein, S Weiss, et al.
Scandinavian Journal of Urology and Nephrology|October 1, 1996
Malignant tumours after renal transplantationD Fahlenkamp, P Reinke, S Kirchner, et al.
European Journal of Nuclear Medicine|January 1, 1988
Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinomaK Buchali, H J Correns, M Schuerer, et al.
The Journal of Urology|August 18, 2004
Advanced cecal carcinoma mimicking Peyronie's diseaseO Gralla, A Roemer, C Kluener, et al.
International Journal of Cancer|April 22, 1997
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancerK Jung, L Nowak, M Lein, et al.
The Journal of Urology|December 18, 2001
Re: a prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. I.D.C. Mitchell, B.L. Croal, A. Dickie, N.P. Cohen and I. Ross. J Urol, 165: 1549-1553, 2001C Stephan, K Jung, D Schnorr, et al.
Clinical Chemistry and Laboratory Medicine|February 24, 2001
Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditionsK Jung, M Lein, B Brux, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Experimental and Clinical Endocrinology|July 1, 1983
Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasiaF Stahl, D Schnorr, W Rohde, et al.
Dermatologische Monatschrift|August 1, 1978
[Influence of oral effective antiandrogens on fertility and sexuality in man and rat (author's transl)]S Engel, F Götz, F Stahl, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 18, 2003
[MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging]D Beyersdorff, U Darsow, C Stephan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1996
Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasiaK Jung, M Lein, S Weiss, et al.
Scandinavian Journal of Urology and Nephrology|October 1, 1996
Malignant tumours after renal transplantationD Fahlenkamp, P Reinke, S Kirchner, et al.
European Journal of Nuclear Medicine|January 1, 1988
Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinomaK Buchali, H J Correns, M Schuerer, et al.
The Journal of Urology|August 18, 2004
Advanced cecal carcinoma mimicking Peyronie's diseaseO Gralla, A Roemer, C Kluener, et al.
International Journal of Cancer|April 22, 1997
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancerK Jung, L Nowak, M Lein, et al.
The Journal of Urology|December 18, 2001
Re: a prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. I.D.C. Mitchell, B.L. Croal, A. Dickie, N.P. Cohen and I. Ross. J Urol, 165: 1549-1553, 2001C Stephan, K Jung, D Schnorr, et al.
Clinical Chemistry and Laboratory Medicine|February 24, 2001
Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditionsK Jung, M Lein, B Brux, et al.
Pageof 12